By Taylor Fox
New York, Jan. 28 – Credit Suisse AG, London Branch priced $4.58 million of 0% autocallable securities due Jan. 27, 2026 linked to the lesser-performing of the ARK Genomic Revolution ETF and the ARK Innovation ETF, according to a 424B2 filing with the Securities and Exchange Commission.
The notes will be automatically called at par plus an annual redemption premium of 20% if the lesser-performing fund closes at or above its initial level on an annual call observation date.
If the notes are not called and the final level of each fund is equal to or greater than its initial level, the payout at maturity will be $2,000 per $1,000 principal amount of notes.
If the final level of either fund is less than its initial level but neither fund finishes below its knock-in level, 50% of its initial level, the payout will be par.
If the final level of either fund is less than its knock-in level, investors will lose 1% for each 1% decline of the lesser performing fund from its initial level.
The agent is Credit Suisse Securities (USA) LLC.
| Issuer: | Credit Suisse AG, London Branch
|
| Issue: | Autocallable securities
|
| Underlying funds: | ARK Genomic Revolution ETF and the ARK Innovation ETF
|
| Amount: | $4,581,000
|
| Maturity: | Jan. 27, 2026
|
| Coupon: | 0%
|
| Price: | Par
|
| Payout at maturity: | If lesser-performing fund finishes at or above its initial level, $2,000 per $1,000 principal amount of notes; if final level of lesser-performing fund is less than its initial level but not below its knock-in level, par; otherwise, 1% loss for each 1% decline of lesser-performing fund
|
| Call: | Automatically at par plus annualized redemption premium of 20% if each fund closes at or above its initial level
|
| Initial levels: | $110.54 for ARK Genomic and $146.08 for ARK Innovation
|
| Knock-in levels: | $55.27 for ARK Genomic and $73.04 for ARK Innovation; 50% of initial levels
|
| Pricing date: | Jan. 22
|
| Settlement date: | Jan. 27
|
| Agent: | Credit Suisse Securities (USA) LLC
|
| Fees: | 4.125%
|
| Cusip: | 22552X5J8
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
